MedTrace Logo

Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer

NCT02280161 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-11-10

No results posted yet for this study

Summary

This research trial studies germ-line mutations in blood and saliva samples from patients with cancer. Studying samples of blood and saliva from patients with cancer in the laboratory may help doctors learn more about how inherited genetic mutations can affect cancer predisposition (an inherited increase in the risk of developing cancer), their impact on treatment response, and their role in cancer development.

Conditions

  • Malignant Neoplasm

Interventions

OTHER

cytology specimen collection procedure

Correlative studies

Sponsors & Collaborators

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Joanne Weidhaas · Jonsson Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-16
Primary Completion
2026-09-16
Completion
2027-09-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02280161 on ClinicalTrials.gov